SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a significant analyst upgrade to a $40 price target, fueling speculation about the company's long-term potential as a best-in-class acquisition target for Big Pharma. Investors are closely monitoring upcoming Phase 3 trial data, with the community actively debating whether the company will secure a buyout or continue as an independent entity.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as retail investors rally behind its long-term potential in AI infrastructure and 6G development, often discussing the stock as a resilient, multi-thematic play despite recent market volatility. Discussion is heavily driven by its strategic partnerships with industry heavyweights like Nvidia, contract wins in defense and optical networking, and persistent institutional accumulation that has fueled bullish sentiment among long-term holders.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo Finance is attracting attention due to its strategic partnership with Franklin Templeton to tokenize traditional assets, fueling investor optimism about its role in bridging Wall Street with decentralized finance. While some in the community remain skeptical of recent price action, many actively discuss its long-term potential as a premier real-world asset (RWA) play.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is experiencing significant volatility following a critical short-seller report alleging improper revenue recognition and channel stuffing practices. While the company has officially refuted these claims and highlighted its robust growth and buyback program, the community remains divided between investors viewing the sell-off as an extreme buying opportunity and those concerned about the lack of a more comprehensive, point-by-point rebuttal from management.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market interest driven by growing anticipation surrounding a potential SpaceX IPO, which investors view as a broader validator for the satellite communications sector. The community is actively debating the company's long-term growth potential and execution roadmap while reacting to recent price volatility and institutional activity.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

Market sentiment for SPY is currently gripped by extreme volatility and 'extreme fear' as participants debate the potential impact of intensifying conflict in the Middle East, with many traders closely monitoring energy supply disruptions and geopolitical escalations. While the community is sharply divided between those bracing for a deeper correction and those anticipating a potential relief rally, active discussions are focused on how these tensions and shifting macro narratives will influence short-term price action.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is gaining significant community attention as a perceived beneficiary of the European natural gas crisis, with investors citing its critical infrastructure and low-float structure as potential catalysts for a squeeze. Traders are actively debating the upside of both the stock and its warrants amid ongoing geopolitical instability, with many highlighting its perceived value compared to other high-volatility oil and gas plays.

Invesco CurrencyShares Japanese Yen Trust - Units of fractional undivided beneficial interest

Invesco CurrencyShares Japanese Yen Trust

The Invesco CurrencyShares Japanese Yen Trust is currently a focal point for traders monitoring the global carry trade, with many market participants warning that a strengthening yen could trigger significant volatility across equities and risk assets. The community is closely debating the potential for a larger unwind of yen-funded positions and questioning the currency's historical role as a reliable safe haven amidst shifting macro instability.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant market attention following the major regulatory milestone of winning marketing approval for its Alpha DaRT cancer treatment in Japan. The community is actively discussing the stock's strong volume, the potential for a breakout toward double digits, and the significant institutional interest driving confidence in its multi-trial pipeline.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining momentum as the company integrates its digital LiDAR sensors with newly acquired AI vision technology to establish a comprehensive physical AI platform. The community is actively discussing the stock's potential to dominate the robotics and defense sectors while closely monitoring upcoming earnings and the scalability of its smart infrastructure deployments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
